Pasireotide for the Prevention of Postoperative Pancreatic Fistula: Time to Curb the Enthusiasm? 2018

Laura Maggino, and Charles M Vollmer
Unit of General and Pancreatic Surgery, Department of Surgery and Oncology, The Pancreas Institute, University of Verona Hospital Trust, Verona, Italy, Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

UI MeSH Term Description Entries
D010185 Pancreatic Fistula Abnormal passage communicating with the PANCREAS. Fistula, Pancreatic,Fistulas, Pancreatic,Pancreatic Fistulas
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone
D016577 Pancreaticoduodenectomy The excision of the head of the pancreas and the encircling loop of the duodenum to which it is connected. Duodenopancreatectomy,Pancreatoduodenectomy,Duodenopancreatectomies,Pancreaticoduodenectomies,Pancreatoduodenectomies

Related Publications

Laura Maggino, and Charles M Vollmer
August 2014, The New England journal of medicine,
Laura Maggino, and Charles M Vollmer
August 2014, The New England journal of medicine,
Laura Maggino, and Charles M Vollmer
May 2014, The New England journal of medicine,
Laura Maggino, and Charles M Vollmer
July 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association,
Laura Maggino, and Charles M Vollmer
August 2006, Nephrology news & issues,
Laura Maggino, and Charles M Vollmer
May 2020, The American surgeon,
Laura Maggino, and Charles M Vollmer
December 2020, The American surgeon,
Laura Maggino, and Charles M Vollmer
May 2019, Journal of the American College of Surgeons,
Laura Maggino, and Charles M Vollmer
October 2022, JAMA internal medicine,
Laura Maggino, and Charles M Vollmer
August 2022, American journal of surgery,
Copied contents to your clipboard!